Supplementary Table S4 from Sitravatinib Targets TYRO3 to Augment the Antitumor Immune Response of PD-1 Blockade in Hepatocellular Carcinoma
收藏数据链接：
官方服务：
资源简介：
Reactome and KEGG enrichment analyses for Huh7 cells pretreated with or without sitravatinib.
创建时间：
2025-11-14
